secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2023-12-11T23:59:59+00:00
Accession:  0001213900-23-094712
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma shareholders approve reincorporation from Delaware to Nevada
------------------------------------------------------------------------

- Proposal 3 approved with 1,589,197 For, 43,858 Against, 10,276 Abstain, 40,875 Broker Non-Vote.
- Reincorporation from Delaware to Nevada was the sole item voted on at reconvened 2023 annual meeting.
- Record date October 12, 2023; 3,109,497 shares outstanding; quorum was present.
- Effective date of reincorporation not disclosed in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023094712/0001213900-23-094712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023094712/ea189856-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-094712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer